Clinical Trial

Genomma Lab Internacional Announces Results for the Third Quarter 2026

MEXICO CITY, Oct. 21, 2026 /PRNewswire/ — Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) (“Genomma” or “the Company”), today announced its results for the third quarter 2026. All figures included herein are stated in nominal Mexican pesos and have been prepared in accordance with…

Source: Read More